Skip Navigation
 

Biennial Report of the Director
National Institutes of Health Fiscal Years 2008 & 2009

Use of Internet Explorer for eRA Modules to be Phased Out by July 19, 2021

eRA is phasing out the use of the Internet Explorer browser for eRA modules effective July 19, 2021. For tips and tricks on troubleshooting browser configuration issues, please go here: Tips & Tricks for Fixing Browser Configuration Issues When Using eRA Modules.


Biennial Report of the Director

Summary of Research Activities by Disease Category
Estimates of Funding for Various Research, Condition, and Disease Categories








The table below provides insight into NIH research funding on the topics addressed in this chapter and is abstracted from the most recent version of NIH's Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC). That publicly available source table displays information that NIH routinely collects on agency-wide funding in areas of special interest. In each such area, the table below indicates whether some of the funding pertains to the topics in this chapter.

Important Notes:

  • NIH does not expressly budget by category. The annual figures reflect amounts that change as a result of science, actual research projects funded, and the NIH budget.
  • The FY 2008 and FY 2009 funding levels are based on actual grants, contracts, intramural research, and other mechanisms of support.
  • FY 2009 data is differentiated by funding source, i.e., non-ARRA (regular appropriations) and ARRA (Recovery Act).
  • The research categories are not mutually exclusive. Because individual research projects can be included in multiple categories, amounts depicted within each column of this table do not add up to 100 percent. For example, Clinical Research includes Clinical Trials. Also, Fragile X Syndrome, Genetics, and Intellectual Disability each overlap to some extent, as do Topical Microbicides, HIV/AIDS, and Prevention.
  • For most of the areas listed, only a portion of the funding pertains to the indicated topic. For example, only a portion of NIH funding on Agent Orange and Dioxin pertains to Neuroscience and Disorders of the Nervous System, but because a fraction does, that area is checked.

ESTIMATES OF FUNDING FOR VARIOUS RESEARCH, CONDITION, AND DISEASE CATEGORIES

  Dollars in Millions (Actual) Biennial Report Disease, Disorder, and Adverse Health Condition Topics
Research/Disease
Area
FY 2008 FY 2009
Non-ARRA
FY 2009
ARRA
Cancer Neuroscience and Disorders of the Nervous System Infectious Diseases and Biodefense Autoimmune Diseases Chronic Diseases and Organ Systems202 Life Stages, Human Development, and Rehabilitation Minority Health and Health Disparities
Acute Respiratory Distress Syndrome 82 103 17 X
Agent Orange & Dioxin 13 13 2 X
Aging 1,965 3,015 554 X X X X X X
Alcoholism 452 441 75 X X X X X X
Allergic Rhinitis (Hay Fever) 6 4 1 X
ALS 43 43 13 X
Alzheimer’s Disease 412 457 77 X X
American Indians/Alaska Natives 142 169 19 X X X X X
Anorexia 7 8 2 X X
Anthrax 134 102 13 X
Antimicrobial Resistance 228 251 52 X
Aphasia 22 22 3 X
Arctic 22 28 6 X X
Arthritis 232 246 65 X X X X X X
Assistive Technology 215 249 43 X X X
Asthma 246 284 51 X X X
Ataxia Telangiectasia 13 13 2 X
Atherosclerosis 460 495 112 X X X
Attention Deficit Disorder (ADD) 60 71 13 X X X
Autism 118 132 64 X X
Autoimmune Disease 762 879 138 X X X
Basic Behavioral and Social Science 1,149 1,410 206 X X X X X X X
Batten Disease 5 5 2 X
Behavioral and Social Science 3,215 3,471 582 X X X X X X X
Biodefense 203 1.736 1,746 213 X X
Bioengineering 2,853 3,155 569 X X X X X X
Biotechnology 5,179 5,619 1,051 X X X X X X X
Brain Cancer 194 234 42 X X
Brain Disorders 3,729 3,538 685 X X X
Breast Cancer 726 722 111 X X X
Cancer 5,570 5,629 1,120 X X X X X X
Cardiovascular 2,027 2,008 396 X X X X X
Cerebral Palsy 28 21 4 X X
Cervical Cancer 69 84 15 X X
Charcot-Marie-Tooth Disease 12 14 2 X
Child Abuse and Neglect Research 30 32 5 X X
Childhood Leukemia 39 47 12 X X
Chronic Fatigue Syndrome 4 5 0 X X X
Chronic Liver Disease and Cirrhosis 241 274 37 X X X
Chronic Obstructive Pulmonary Disease 75 96 18 X
Climate Change 4 4 2 X X
Clinical Research 9,629 10,336 1,854 X X X X X X X
Clinical Trials 3,562 2,966 485 X X X X X X X
Colo-Rectal Cancer 274 281 48 X X
Comparative Effectiveness Research + 194 246 X X X X X X X
Complementary and Alternative Medicine 430 513 70 X X X X X
Conditions Affecting Unborn Children 81 95 8 X X X
Contraception/Reproduction 473 427 65 X
Cooley’s Anemia 22 21 3 X
Cost-Effectiveness Research 49 52 16 X X X X X
Crohn’s Disease 51 55 14 X X
Cystic Fibrosis 90 86 13 X X X
Dental/Oral and Craniofacial Disease 463 490 75 X X X X X X X
Depression 402 402 48 X X X
Diabetes204 1,080 1,030 121 X X X X X
Diagnostic Radiology 1,095 976 206 X X X
Diethylstilbestrol (DES) 4 4 1 X
Digestive Diseases 1,426 1,538 243 X X X X X
Digestive Diseases (Gallbladder) 7 7 1 X
Digestive Diseases (Peptic Ulcer) 14 17 3 X X X X
Down Syndrome 17 18 4 X X
Drug Abuse (NIDA only) 205 1,007 1,040 135 X X X X X X
Duchenne/Becker Muscular Dystrophy 22 27 6 X X
Dystonia 15 16 2 X
Eating Disorders + 26 5 X X X
Emerging Infectious Diseases 2,098 2,080 307 X X
Emphysema 29 28 11 X
Endometriosis 15 15 2 X X X
Epilepsy 145 128 21 X
Estrogen 245 235 34 X X X
Eye Disease and Disorders of Vision 796 862 129 X X
Facioscapulohumeral Muscular Dystrophy 3 3 2 X
Fetal Alcohol Syndrome 34 34 7 X X X
Fibroid Tumors (Uterine) 16 18 2 X X X
Fibromyalgia 12 11 2 X
Food Safety 244 262 37 X
Fragile X Syndrome 26 27 5 X X X
Frontotemporal Dementia (FTD) 17 22 2 X X
Gene Therapy 249 221 28 X X X X X
Gene Therapy Clinical Trials 16 11 0 X X X X X
Genetic Testing 383 316 76 X X
Genetics 6,872 7,278 1,676 X X X X X X X
Global Warming Climate Change 1 3 1 X
Health Disparities 206 2,614 2,806 434 X X X X X X X
Health Effects of Climate Change 286 179 35 X X
Health Services 743 1,102 316 X X X X X X X
Heart Disease 1,217 1,202 227 X X X
Heart Disease - Coronary Heart Disease 367 426 98 X X X
Hematology 894 908 151 X X X X
Hepatitis 180 178 23 X X X
Hepatitis - A 6 4 0 X
Hepatitis - B 53 51 6 X X X X
Hepatitis - C 93 97 12 X X X
HIV/AIDS 207,208 2,928 3,019 319 X X X X X
Hodgkin’s Disease 16 26 1 X
HPV and/or Cervical Cancer Vaccines 19 25 2 X X X
Human Fetal Tissue 209 40 41 22 X X X X
Human Genome 1,259 1,775 566 X X X
Huntington’s Disease 51 57 12 X
Hyperbaric Oxygen 4 3 0 X
Hypertension 263 266 41 X X X X
Immunization 1,734 1,773 191 X X X X X
Infant Mortality/(LBW) 246 246 32 X X X X
Infectious Diseases 3,575 3,627 526 X X X X
Infertility 73 75 17 X
Inflammatory Bowel Disease 81 91 22 X X
Influenza 204 316 46 X
Injury (total) Accidents/Adverse Effects 299 340 58 X X X
Injury - Childhood Injuries 26 33 3 X
Injury - Trauma - (Head and Spine) 150 161 33 X X
Injury - Traumatic Brain Injury 59 71 15 X X
Injury - Unintentional Childhood Injury 15 19 1 X X
Interstitial Cystitis 10 11 1 X
Kidney Disease 523 570 85 X X X X X
Lead Poisoning 9 11 3 X X
Liver Cancer 89 94 12 X X
Liver Disease 562 572 79 X X
Lung 1,211 1,265 234 X X
Lung Cancer 169 178 36 X
Lupus 126 115 19 X X
Lyme Disease 22 25 5 X X
Lymphoma 193 184 22 X X X X
Macular Degeneration 135 85 8 X X X
Malaria 132 110 11 X
Malaria Vaccine 32 34 3 X
Mental Health 2,086 2,129 382 X X X X
Mental Retardation (Intellectual and Developmental Disabilities (IDD)) 350 281 94 X X
Methamphetamine 67 69 13 X X
Mind and Body 567 494 90 X X X
Minority Health 210 2,396 2,592 378 X X X X X X X
Mucopolysaccharidoses (MPS) 7 7 0 X X X X
Multiple Sclerosis 169 137 25 X X
Muscular Dystrophy 56 66 17 X X
Myasthenia Gravis 9 9 3 X X
Myotonic Dystrophy 9 9 4 X
Nanotechnology 211 304 343 73 X X X
Networking Information Technology R&D 212 911 1,174 168 X
Neurodegenerative 1,621 1,553 262 X
Neurofibromatosis 14 17 2 X X
Neuropathy 121 119 13 X X X
Neurosciences 5,224 5,320 848 X X X X X X X
Nutrition 1,391 1,400 205 X X X X X X
Obesity 664 745 117 X X X X X
Organ Transplantation 175 139 32 X X X
Orphan Drug 645 441 118 X X X X
Osteogenesis Imperfecta 5 5 1 X
Osteoporosis 183 198 21 X X
Otitis Media 18 15 7 X X
Ovarian Cancer 96 102 13 X
Paget’s Disease 1 1 1 X
Pain Conditions - Chronic 279 333 53 X X X
Parkinson’s Disease 152 162 24 X
Pediatric 2,771 2,996 505 X X X X X X X
Pediatric AIDS 213 241 227 20 X X X X
Pediatric Research Initiative 209 214 256 X X X
Pelvic Inflammatory Disease 3 3 1 X X X
Perinatal - Birth - Preterm (LBW) 197 177 23 X X X
Perinatal - Neonatal Respiratory Distress Syndrome 18 31 5 X
Perinatal Period - Conditions Originating in Perinatal Period 449 470 65 X X
Pick’s Disease 2 2 - X X
Pneumonia 93 108 15 X
Pneumonia & Influenza 295 392 58 X
Polycystic Kidney Disease 41 38 7 X X
Prevention 4,623 5,332 844 X X X X X X X
Prostate Cancer 290 310 47 X X
Psoriasis 8 13 3 X
Regenerative Medicine 723 799 144 X X X X X X
Rehabilitation 403 404 75 X X X
Rett Syndrome 9 9 4 X X
Reye’s Syndrome 0 - - X
Rural Health 170 186 42 X X X X
Schizophrenia 249 265 85 X X X
Scleroderma 20 21 2 X
Septicemia 95 92 19 X
Sexually Transmitted Diseases/Herpes 245 250 43 X X X X X
Sickle Cell Disease 80 63 14 X X
Sleep Research 225 217 33 X X
Small Pox 94 94 4 X
Smoking and Health 310 329 78 X X X X X
Spina Bifida 15 14 3 X X
Spinal Cord Injury 80 80 14 X X
Spinal Muscular Atrophy 10 11 3 X
Stem Cell Research 938 1,044 187 X X X X X X
Stem Cell Research - Embryonic - Human 214 88 120 23 X X X X X
Stem Cell Research - Embryonic - Non-Human 150 148 29 X X X X X X
Stem Cell Research - Nonembryonic - Human 297 339 58 X X X X X X
Stem Cell Research - Nonembryonic - Non-Human 497 550 88 X X X X X X
Stem Cell Research - Umbilical Cord Blood / Placenta 46 49 10 X X X X X X
Stem Cell Research- Umbilical Cord Blood/ Placenta - Human 38 42 9 X X X X X X
Stem Cell Research - Umbilical Cord Blood/ Placenta - Non-Human 9 10 1 X X X X X X
Stroke 296 329 54 X X X
Substance Abuse 215 1,763 1,653 245 X X X X X X
Sudden Infant Death Syndrome 29 22 6 X X X
Suicide 39 36 15 X X
Teenage Pregnancy 21 23 5 X
Temporomandibular Muscle/Joint Disorder 19 15 1 X X
Tobacco 311 331 78 X X X X
Topical Microbicides 102 92 7 X X
Tourette Syndrome 8 7 3 X
Transmissible Spongiform Encephalopathy (TSE) 44 43 4 X X
Transplantation 519 571 94 X X X X
Tuberculosis 142 189 27 X
Tuberculosis Vaccine 18 15 3 X
Tuberous Sclerosis 20 20 3 X
Urologic Diseases 534 578 81 X X X
Uterine Cancer 16 25 4 X
Vaccine Related 1,632 1,593 185 X X X X
Vaccine Related (AIDS) 216 556 561 35 X X
Vector-Borne Diseases 417 401 66 X
Violence Research 183 182 21 X
Vulvodynia + 1 1 X X
West Nile Virus 39 59 7 X
Women's Health 217 3,514 3,725 506 X X X X X X X

202 Chronic diseases and organ systems pertain to almost every area listed in the table. Instead of checking most areas, only the areas addressed in this chapter's section on chronic disease are checked.
203 Reporting for this category does not follow the standard RCDC process. The total amount reported is consistent with reporting requirements for this category to the U.S. Office of Management & Budget (OMB). The project listing does not include non-project or other support costs associated with the annual total for this category. Additional information on this category is available at http://www3.niaid.nih.gov/topics/BiodefenseRelated/default.htm
204 Includes research funded from the Type 1 diabetes appropriation of $150,000,000. These are project listings only.
205 Reporting for this category does not follow the standard RCDC process. Spending is reported consistent with U.S. Office of National Drug Control Policy (ONDCP) requirements (Only NIDA). More information on this area is available at http://www.nida.nih.gov/drugpages.html.
206 Reporting for this category does not follow the standard RCDC process. This category assigns project funding according to populations tracked by gender or ethnicity. The databases used to track gender/ethnicity are complex and not currently compatible with the RCDC system.
207 Reporting for this category does not follow the standard RCDC process. These are project listings only and non-project or other support costs associated with the annual total for the category are not included. More information on this area is available at http://www.oar.nih.gov/.
208 Includes research on HIV/AIDS, its associated opportunistic infections, malignancies, and clinical manifestations as well as basic science that also benefits a wide spectrum of non-AIDS disease research.
209 Reporting for this category does not follow the standard RCDC process. This category uses a non-standard approach involving subject matter expert reviews of manually collected project listings.
210 Reporting for this category does not follow the standard RCDC process. This category assigns project funding according to populations tracked by gender or ethnicity. The databases used to track gender/ethnicity are complex and not currently compatible with the RCDC system.
211 The data provided reflects funding amounts reported by the NIH RCDC process for this category. Actual and estimate levels presented on this site supersede FY 2009-2011 amounts detailed in OMB MAX DE application tables that were based on preliminary FY 2009 funding support information.
212 Ibid.
213 Reporting for this category does not follow the standard RCDC process. These are project listings only and non-project or other support costs associated with the annual total for the category are not included. More information on the budget associated with the category is available at http://www.oar.nih.gov/. Research reported for this category is also captured under the broader HIV/AIDS category.
214 Human embryonic stem cell research projects awarded with restrictions may have been included in the FY 2009 report.
215 Reporting for this category does not follow the standard RCDC process. This category includes all spending reported under the Drug Abuse category as well as projects categorized under the broader area of Substance Abuse. These are project listings only. More information on this area is available at http://www.nida.nih.gov/drugpages.html.
216 Reporting for this category does not follow the standard RCDC process. These are project listings only and non-project or other support costs associated with the annual total for the category are not included. More information on the budget associated with the category is available at http://www.oar.nih.gov/. Research reported for this category is also captured under the broader HIV/AIDS category.
217 Reporting for this category does not follow the standard RCDC process. This category assigns project funding according to populations tracked by gender or ethnicity. The databases used to track gender/ethnicity are complex and not currently compatible with the RCDC system.